Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/BUTYLIN SYRUP 1.5 mg/5 ml

Approved

THERAPEUTIC

BUTYLIN SYRUP 1.5 mg/5 ml

HOVID BHD🇸🇬 Health Sciences Authority

Approval Date: Mar 18, 1995
Approval ID: 184a8d799dce383c
Company: HOVID BHD
Type: Therapeutic

Approval Details

Approval Id: 184a8d799dce383c
Drug Name: BUTYLIN SYRUP 1.5 mg/5 ml
Product Name: BUTYLIN SYRUP 1.5 mg/5 ml
Approval Number: SIN08075P
Approval Date: 1995-03-18
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Licence Holder: GOLDPLUS UNIVERSAL PTE LTD
Drug Type: Therapeutic
Forensic Classification: Pharmacy Only
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: R03CC03
Atc Item Name: terbutaline
Pharma Manufacturer Name: GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path: /organization/goldplus-universal-pte-ltd

Active Ingredients

TERBUTALINE SULPHATE

1.5 mg/5 ml

TERBUTALINE SULPHATE

1.5 mg/5 ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 18, 1995

Approval ID

184a8d799dce383c

Type

Therapeutic

Back to HSA Approvals

BUTYLIN SYRUP 1.5 mg/5 ml - HSA Drug Approval Details